Skip to main content

Table 4 Alleles’ frequencies in the studied group

From: The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients

SNPs

Alleles carrier

Frequency % (N)

ERCC1 118 C/T

C allele

54.55 (48)

T allele

45.45 (40)

ERCC1 8092 C/A

C allele

62.5 (55)

A allele

37.5 (33)

ERCC2 312 G/A

G allele

67.05 (59)

A allele

32.95 (29)

ERCC2 751 A/C

A allele

70.7 (58)

C allele

29.3 (24)

Back to article page

BMC Medical Genetics

ISSN: 1471-2350

Contact us